On the demand for telemedicine: Evidence from the COVID-19 pandemic.


Journal

Health economics
ISSN: 1099-1050
Titre abrégé: Health Econ
Pays: England
ID NLM: 9306780

Informations de publication

Date de publication:
07 2022
Historique:
revised: 07 03 2022
received: 25 01 2021
accepted: 05 04 2022
pubmed: 10 5 2022
medline: 11 6 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine has remained low. Using administrative records and a difference-in-differences methodology, we estimate the change in demand for telemedicine experienced after the onset of the COVID-19 epidemic and the imposition of mobility restrictions. We find that the number of telemedicine calls made during the pandemic increased by 230 percent compared to the pre-pandemic period. The effects were mostly driven by older individuals with preexisting conditions who used the service for internal medicine consultations. The demand for telemedicine remained relatively high even after mobility restrictions were relaxed, which is consistent with telemedicine being an "experience good." These results are a proof of concept for policy makers to use such relatively low-cost medical consultations, made possible by new technologies, to provide needed expansion of access to health care.

Identifiants

pubmed: 35527351
doi: 10.1002/hec.4523
pmc: PMC9324159
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1491-1505

Informations de copyright

© 2022 The Authors. Health Economics published by John Wiley & Sons Ltd.

Références

N Engl J Med. 2018 Jan 11;378(2):104-106
pubmed: 29320653
Health Econ. 2016 Sep;25(9):1148-62
pubmed: 27381724
Health Aff (Millwood). 2017 Mar 1;36(3):485-491
pubmed: 28264950
Pediatrics. 2019 Sep;144(3):
pubmed: 31371465
N Engl J Med. 2016 Jul 14;375(2):154-61
pubmed: 27410924
Telemed J. 1999 Fall;5(3):223-44
pubmed: 10908437
Milbank Q. 2012 Mar;90(1):107-34
pubmed: 22428694
J Am Med Inform Assoc. 2021 Jan 15;28(1):33-41
pubmed: 32866264
Telemed J E Health. 2011 Sep;17(7):530-5
pubmed: 21767150
J Telemed Telecare. 2005;11(2):60-70
pubmed: 15829049
J Telemed Telecare. 2007;13(6):303-9
pubmed: 17785027
J Telemed Telecare. 2018 Dec;24(10):676-682
pubmed: 30343658
Disaster Med Public Health Prep. 2020 Apr 13;:1-5
pubmed: 32279689
Manage Sci. 2018 Dec;64(12):5461-5480
pubmed: 33033417
Econ Hum Biol. 2016 May;21:122-36
pubmed: 26851396
Health Econ. 2022 Jul;31(7):1491-1505
pubmed: 35527351
Health Econ. 2005 Jun;14(6):559-73
pubmed: 15497196
Econ Inq. 2011;49(3):876-98
pubmed: 22022733
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
J Med Syst. 1995 Apr;19(2):81-91
pubmed: 7602255
BMC Med Inform Decis Mak. 2012 Jan 04;12:1
pubmed: 22217121
JAMA. 2018 Nov 27;320(20):2147-2149
pubmed: 30480716
Prev Med. 2018 Jul;112:76-87
pubmed: 29626555
Stroke. 1999 Feb;30(2):464-9
pubmed: 9933289
Intern Med J. 2012 Jul;42(7):780-5
pubmed: 21627743
J Gen Intern Med. 2016 Mar;31(3):269-75
pubmed: 26269131
BMJ Open. 2017 Aug 3;7(8):e016242
pubmed: 28775188
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Sci Rep. 2020 Nov 26;10(1):20742
pubmed: 33244071
AIDS Behav. 2015 Nov;19(11):2069-75
pubmed: 25987190
Annu Rev Econom. 2014 Aug;6:663-688
pubmed: 25520759
CMAJ. 2001 Sep 18;165(6):765-71
pubmed: 11584564
J Public Econ. 2020 Sep;189:104241
pubmed: 32834179
Telemed J E Health. 2019 Feb;25(2):132-136
pubmed: 29847224
Am J Manag Care. 2019 Jan;25(1):40-44
pubmed: 30667610
Annu Rev Public Health. 2013;34:431-47
pubmed: 23297657
J Telemed Telecare. 2008;14(3):109-14
pubmed: 18430271
West J Emerg Med. 2016 Nov;17(6):713-720
pubmed: 27833678
J Telemed Telecare. 2016 Dec;22(8):504-512
pubmed: 27686648
Health Aff (Millwood). 2018 Dec;37(12):2060-2068
pubmed: 30633679
Telemed J E Health. 2020 Sep;26(9):1178-1183
pubmed: 31880502
Psychol Sci. 2013 Sep;24(9):1763-9
pubmed: 23873580
Int J Med Inform. 2010 Nov;79(11):736-71
pubmed: 20884286

Auteurs

Matias Busso (M)

Research Department, Inter-American Development Bank, Washington, District of Columbia, USA.

Maria P Gonzalez (MP)

Research Department, Inter-American Development Bank, Washington, District of Columbia, USA.

Carlos Scartascini (C)

Research Department, Inter-American Development Bank, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH